Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Epigral has informed that the meeting of the Board of Directors of the Company will be held on Wednesday, 24th January, 2024, at the Registered Office of the Company, to consider, approve and take on record: Un-Audited Financial Results (Standalone & Consolidated) of the Company for the Third Quarter and Nine Months ended on 31st December, 2023, along with Limited Review Report of the Statutory Auditors thereon and Any other business with the permission of the Chair. The intimation is being given for the information of Shareholders/ Members.
The above information is a part of company’s filings submitted to BSE.
